Vir Biotechnology (VIR) Cash from Operations (2018 - 2025)

Vir Biotechnology's Cash from Operations history spans 8 years, with the latest figure at 25876000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 70.47% to 25876000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 391781000.0, a 12.23% increase, with the full-year FY2025 number at 391781000.0, up 12.23% from a year prior.
  • Cash from Operations hit 25876000.0 in Q4 2025 for Vir Biotechnology, up from 167570000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for VIR hit a ceiling of 960136000.0 in Q2 2022 and a floor of 389247000.0 in Q2 2023.
  • Historically, Cash from Operations has averaged 62700.0 across 5 years, with a median of 88582000.0 in 2021.
  • Biggest five-year swings in Cash from Operations: soared 1416.46% in 2021 and later crashed 407.26% in 2023.
  • Tracing VIR's Cash from Operations over 5 years: stood at 7695000.0 in 2021, then skyrocketed by 356.48% to 35126000.0 in 2022, then crashed by 407.26% to 107927000.0 in 2023, then increased by 18.8% to 87635000.0 in 2024, then soared by 70.47% to 25876000.0 in 2025.
  • Business Quant data shows Cash from Operations for VIR at 25876000.0 in Q4 2025, 167570000.0 in Q3 2025, and 120219000.0 in Q2 2025.